![Derek DiRocco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek DiRocco
Direttore/Membro del Consiglio presso
EVOMMUNE, INC.
Patrimonio netto: 14 049 $ in data 31/07/2026
Profilo
Derek DiRocco is currently Director at Suzhou Connect Biopharma Co. Ltd., 89Bio Ltd., Rivus Pharmaceuticals, Inc., Forward Therapeutics, Inc., and Sera Medicines LLC.
Dr. DiRocco is Independent Director at Acrivon Therapeutics, Inc. since 2021 and Mineralys Therapeutics, Inc. since 2022.
Dr. DiRocco is Partner at RA Capital Management LP (Private Equity) since 2020 and at RA Capital Management LP since 2020.
Former roles include Independent Director at iTeos Therapeutics, Inc. from 2020 to 2023, Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2023, Independent Non-Executive Director at Achilles Therapeutics Plc from 2019 to 2022, Independent Director at Werewolf Therapeutics, Inc. from 2020 to 2025, and Independent Director at 89bio, Inc. from 2018 to 2025.
Other former positions include Non-Executive Director at Achilles Therapeutics UK Ltd., Independent Director at Day One Biopharmaceuticals, Inc., Director at Canbridge Pharmaceuticals, Inc. (United States), Independent Non-Executive Director at Connect Biopharma Holdings Ltd., and Director at Canbridge Pharmaceuticals, Inc. Education includes an undergraduate degree from College of the Holy Cross (Massachusetts) conferred in 2002 and a doctorate from the University of Washington conferred in 2009.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2026 | 9.366 ( 0,02% ) | 14 049 $ | 31/07/2026 | |
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 14/04/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Derek DiRocco
| Società | Posizione | Inizio |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2021 |
| MINERALYS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/05/2022 |
| EVOMMUNE, INC. | Direttore/Membro del Consiglio | 01/10/2024 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Analyst-Equity | 01/07/2013 |
Forward Therapeutics, Inc.
 Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Direttore/Membro del Consiglio | - |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Direttore/Membro del Consiglio | - |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Direttore/Membro del Consiglio | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Investitore di Private Equity | 01/12/2017 |
Precedenti posizioni note di Derek DiRocco
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Derek DiRocco
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
78
Relazioni di 1° grado
20
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Operates as a biopharmaceutical company which research, development and commercialization of transformative therapies | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
CANbridge Pharmaceuticals Inc.
 CANbridge Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Forward Therapeutics, Inc.
Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Health Technology |
